2012-11-12 23:45:01 - Enzon Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report - a new company profile report on companiesandmarkets.com

Enzon Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company´s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.

Features:

- Detailed information on Enzon Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Enzon Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Enzon Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Enzon Pharmaceuticals, Inc.
-

 

 

Intelligence on Enzon Pharmaceuticals, Inc.nv´s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Enzon Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

Enzon Pharmaceuticals (Enzon) is a biopharmaceutical company focused on research and development of innovative therapeutics for cancer patients. The company operates in the US. It is headquartered in Bridgewater, New Jersey and employed 126 people as of December 31, 2010. The company recorded revenues of $97.9 million during the financial year ended December 2010 (FY2010), an increase of 90.4% over FY2009. The operating loss of the company was $0.6 million during FY2010, as compared to operating loss of $57.1 million in FY2009. The net profit was $177.2 million in FY2010, as compared to net loss of $0.7 million in FY2009.
Reasons to Purchase:

- Gain understanding of Enzon Pharmaceuticals, Inc. and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Enzon Pharmaceuticals, Inc. as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers´ businesses better
- Stay up to date on Enzon Pharmaceuticals, Inc.´s business structure, strategy and prospects

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Company Profile Reports www.companiesandmarkets.com/Market/All/Company-Profile?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.